{"id":"W3213036992","doi":"10.3389/fcvm.2021.789931","title":"Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol","year":2021,"lang":"en","type":"review","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ezetimibe; Medicine; Statin; Drug; PCSK9; Cholesterol; Clinical trial; Pharmacology; Adverse effect; Residual risk; Atherosclerotic cardiovascular disease; Internal medicine; Disease; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00320967,0.001282787,0.01114344,0.001027328,0.0002453398,0.00004226454,0.0003324649,0.0008216538,0.00003475126],"category_scores_gemma":[0.0004108819,0.001010765,0.008147824,0.001236317,0.0002157659,0.0001096574,0.0001333577,0.0009670424,0.00001328301],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002080386,"about_ca_system_score_gemma":0.001197145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001302636,"about_ca_topic_score_gemma":0.00005683838,"domain_scores_codex":[0.9932536,0.0004964551,0.001774449,0.001818098,0.00148952,0.001167908],"domain_scores_gemma":[0.9953356,0.000094192,0.0003778966,0.003257487,0.0003340029,0.0006007965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000291563,0.0001874259,0.00002234624,0.02799693,0.0109031,0.0007275965,0.0002487756,0.00004228941,7.47959e-7,0.000004741577,0.001573316,0.9582636],"study_design_scores_gemma":[0.006284908,0.0005323149,0.0001142072,0.05437418,0.01550295,0.0007232039,0.0004301973,0.00007765225,0.00002251375,0.00001057492,0.9211736,0.0007537263],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003520486,0.9131265,0.07471858,0.0001615964,0.003023383,0.00851054,0.00006108027,0.0001091374,0.0002539923],"genre_scores_gemma":[0.00005337542,0.9809434,0.009810357,0.0001152562,0.003816389,0.003278928,0.001142589,0.0003090952,0.0005305866],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9575098,"threshold_uncertainty_score":0.9999924,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02993258624970574,"score_gpt":0.3200143753985646,"score_spread":0.2900817891488589,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}